These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7954840)

  • 1. Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model.
    Abdel-Wahab Z; Li WP; Osanto S; Darrow TL; Hessling J; Vervaert CE; Burrascano M; Barber J; Seigler HF
    Cell Immunol; 1994 Nov; 159(1):26-39. PubMed ID: 7954840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.
    Miller AR; McBride WH; Dubinett SM; Dougherty GJ; Thacker JD; Shau H; Kohn DB; Moen RC; Walker MJ; Chiu R
    Blood; 1993 Dec; 82(12):3686-94. PubMed ID: 8260705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lung tumor cell secretion of interleukin-2 for protection against tumor engraftment.
    Alosco T; Gansbacher B; Bankert R; Takita H; Petrelli N
    Ann Surg Oncol; 1994 May; 1(3):229-35. PubMed ID: 7842293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts.
    Tsai SC; Gansbacher B; Tait L; Miller FR; Heppner GH
    J Natl Cancer Inst; 1993 Apr; 85(7):546-53. PubMed ID: 8455201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
    Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
    Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector.
    Kim JH; Gong SJ; Yoo NC; Lee H; Shin DH; Uhm HD; Jeong SJ; Cho JY; Rha SY; Kim YS; Chung HC; Roh JK; Min JS; Kim BS
    Oncol Rep; 1999; 6(1):49-54. PubMed ID: 9864400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
    Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
    Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human gastric carcinoma transduced with the IL-2 gene: increased sensitivity to immune effector cells in vitro and in vivo.
    Nagashima S; Kashii Y; Reichert TE; Suminami Y; Suzuki T; Whiteside TL
    Int J Cancer; 1997 Jul; 72(1):174-83. PubMed ID: 9212240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy.
    Kimura M; Tagawa M; Takenaga K; Kondo F; Yamaguchi T; Saisho H; Nakagawara A; Sakiyama S
    Cancer Lett; 1998 Jun; 128(1):47-53. PubMed ID: 9652792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.
    Gansbacher B; Zier K; Cronin K; Hantzopoulos PA; Bouchard B; Houghton A; Gilboa E; Golde D
    Blood; 1992 Dec; 80(11):2817-25. PubMed ID: 1450408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
    Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
    Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
    Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
    Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on characterization and tumorigenesis of an interleukin 2 gene transduced human breast carcinoma cell line].
    Su N; Zhang X; Zwiebel JA
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):228-31. PubMed ID: 9275658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
    Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
    Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.
    Hollingsworth SJ; Darling D; Gäken J; Hirst W; Patel P; Kuiper M; Towner P; Humphreys S; Farzaneh F; Mufti GJ
    Br J Cancer; 1996 Jul; 74(1):6-15. PubMed ID: 8679459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer gene therapy: transgenic immunotherapy.
    Su N; Ojeifo JO; MacPherson A; Zwiebel JA
    Breast Cancer Res Treat; 1994; 31(2-3):349-56. PubMed ID: 7881111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of a vascular ocular tumor growth by IL-12 gene transfer.
    Albini A; Fassina G; Nicolò M; Dell'Eva R; Vené R; Cammarota R; Barberis M; Noonan DM
    Clin Exp Metastasis; 2007; 24(7):485-93. PubMed ID: 17653825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.